share_log

HC Wainwright & Co. Maintains Buy on Inozyme Pharma, Maintains $16 Price Target

HC Wainwright & Co. Maintains Buy on Inozyme Pharma, Maintains $16 Price Target

HC Wainwright & Co.維持對Inozyme Pharma的買入,維持16美元的目標股價
Moomoo 24/7 ·  03/13 09:29

HC Wainwright & Co. analyst Edward White maintains Inozyme Pharma (NASDAQ:INZY) with a Buy and maintains $16 price target.

HC Wainwright & Co. 分析師愛德華·懷特維持Inozyme Pharma(納斯達克股票代碼:INZY)的買入並維持16美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論